IAPP and type 2 diabetes mellitus: Few studies utilize transgenic mice that express the human variant of amylin which forms amyloid (Aitken et al., 2017), and are thereby unable to measure the effectiveness of the compound against amyloid formation that evidence suggests is involved in T2DM pathogenesis.